Therapeutic drug monitoring in breast cancer therapy – LC-MS/MS method for quantification of the CDK4/6 inhibitors abemaciclib, palbociclib, ribociclib, and major metabolites abemaciclib M20 and M2 in human serum

Titel:: Therapeutic drug monitoring in breast cancer therapy – LC-MS/MS method for quantification of the CDK4/6 inhibitors abemaciclib, palbociclib, ribociclib, and major metabolites abemaciclib M20 and M2 in human serum
Dokumenttyp:: Zeitschriftenaufsatz
Autor(en):: Habler, Katharina; Kalla, Anne-Sophie; Rychlik, Michael; Vogeser, Michael; Teupser, Daniel
Zeitschriftentitel:: Journal of Pharmaceutical and Biomedical Analysis
Jahr:: 2023
Band / Volume:: 225
Seitenangaben Beitrag:: 115211
Volltext / DOI:: doi:10.1016/j.jpba.2022.115211
Verlag / Institution:: Elsevier BV
E-ISSN:: 0731-7085
Publikationsdatum:: 01.02.2023
BibTeX